Quinn et al. [1] have done an exceptional work. I offer some further suggestion.
The Authors state:
(page 8) “the progression of the pandemic was largely independent of government measures”. Indeed, some government measures were even counterproductive for hard outcomes. For example, all-cause mortality excess in 2020 (pre-vaccination era) versus mean mortality 2015–2019 (Our World in Data) was not favorably associated with the lockdown index (Oxford University Database). Rather, it was slightly unfavorably associated with mortality both globally, and in subanalysis by gross domestic product per capita ($ <21,000; 21,000 to <45,000; ≥45,000), population size (<17; 17 to 50, >50 M), population density (inhabitants per km2: <100, 100 to <1,000, ≥1,000), and proportion of older adults (75–84, or ≥85 years).
(page 15) “the incidence of… transient myocarditis and/or pericarditis is not ‘rare’, but rather ‘uncommon’”. The correct term is ‘common’ (i.e. 2.33%–2.8% in the two cited [1] studies, as per international rules).
(page 16) “some studies comparing all-cause mortalities between vaccinated and unvaccinated groups found slightly increased risks among vaccinated groups”. Indeed, in the cited study, in the 2 years 2021 and 2022, the mortality risk in vaccinated people with one or two doses was statistically significant, and twice or more than the risk of unvaccinated. Moreover, a study based on the UK Office for National Statistics (ONS) data [2] shows that the regression lines, both for all-cause deaths and for non-COVID-19 deaths, start from very low values for all the age groups, with almost linear progressive increases as the months progress. For the age groups 18–39, 80–89 and 90+ years, both regression lines intersect and overcome the reference line of unvaccinated during the study period. The same occurs for the age 50–59, limited to non-COVID-19 deaths. For the other age groups, the month of the intersection was predicted calculating the angular coefficients. The last intersections would have occurred in 2024, but the ONS stopped publishing mortality data by vaccination status after May 2023.
(page 17) “by late 2021, it was abundantly clear that the vaccines did not prevent COVID-19 infection”. Indeed, by March 2022 it was clear that, in the Delta variant era, they did not prevent even the transmission; instead, they significantly increase the transmission from infected people, ≥90 days after dose 2 [3].
Moreover, many recent studies (e.g., [4, 5]) showed that multiple inoculations are progressively and proportionally associated with SARS-CoV-2 infections.
Statements
Author contributions
The author confirms being the sole contributor of this work and has approved it for publication.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Conflict of interest
The author declare that they do not have any conflicts of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
References
1.
Quinn GA Connolly R ÓhAiseadha C Hinds P Bagus P Brown RB et al What Lessons Can Be Learned from the Management of the COVID-19 Pandemic? Int J Public Health (2025) 70:1607727. 10.3389/ijph.2025.1607727
2.
Alessandria M Malatesta G Di Palmo G Cosentino M Donzelli A . All-Cause Mortality According to COVID-19 Vaccination Status: An Analysis of the UK Office for National Statistics Public Data. F1000Res (2025) 13:886. 10.12688/f1000research.154058.2
3.
Prunas O Warren JL Crawford FW Gazit S Patalon T Weinberger DM et al Vaccination with BNT162b2 Reduces Transmission of SARS-CoV-2 to Household Contacts in Israel. Science (2022) 375(6585):1151–4. 10.1126/science.abl4292
4.
Shrestha NK Burke PC Nowacki AS Simon JF Hagen A Gordon SM . Effectiveness of the Coronavirus Disease 2019 Bivalent Vaccine. Open Forum Infect Dis (2023) 10(6):ofad209. 10.1093/ofid/ofad209
5.
Chalupka A Richter L Chakeri A El-Khatib Z Theiler-Schwetz V Trummer C et al Effectiveness of a Fourth SARS-CoV-2 Vaccine Dose in Previously Infected Individuals from Austria. Eur J Clin Invest (2024) 54(3):e14136. 10.1111/eci.14136
Summary
Keywords
COVID-19 lockdown, COVID-19 vaccine myo-pericarditis, vaccinated vs. unvaccinated mortality, infection and transmission, boosters and SARS-CoV-2 infections
Citation
Donzelli A (2026) Lessons to Be Learned From the COVID-19 Pandemic: Some Further Ideas. Int. J. Public Health 70:1609023. doi: 10.3389/ijph.2025.1609023
Received
28 August 2025
Accepted
17 December 2025
Published
02 February 2026
Volume
70 - 2025
Edited by
Nino Kuenzli, Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland
Updates
Copyright
© 2026 Donzelli.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alberto Donzelli, adonzelli55@outlook.it
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.